athenahealth, Inc. (NASDAQ:ATHN) Upgraded by TheStreet to B-

TheStreet upgraded shares of athenahealth, Inc. (NASDAQ:ATHN) from a c rating to a b- rating in a research note published on Thursday.

Several other analysts have also issued reports on the company. Jefferies Group LLC reaffirmed a sell rating and issued a $95.00 target price on shares of athenahealth in a research note on Friday, March 24th. BidaskClub raised athenahealth from a hold rating to a buy rating in a research note on Saturday, June 24th. Citigroup Inc. set a $128.00 target price on athenahealth and gave the stock a buy rating in a research note on Monday, May 1st. Cantor Fitzgerald reaffirmed a buy rating and issued a $118.00 target price (down previously from $135.00) on shares of athenahealth in a research note on Thursday, April 27th. Finally, Piper Jaffray Companies reaffirmed an overweight rating and issued a $160.00 target price on shares of athenahealth in a research note on Tuesday, April 4th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and twelve have assigned a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of $146.45.

Shares of athenahealth (NASDAQ ATHN) traded up 8.44% on Thursday, reaching $155.93. 2,286,356 shares of the company were exchanged. The firm has a market capitalization of $6.23 billion, a PE ratio of 197.88 and a beta of 1.79. The stock’s 50-day moving average is $141.51 and its 200 day moving average is $122.62. athenahealth has a 12-month low of $90.11 and a 12-month high of $158.66.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. athenahealth had a return on equity of 7.11% and a net margin of 2.80%. athenahealth’s revenue for the quarter was up 15.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.34 earnings per share. On average, analysts forecast that athenahealth will post $1.86 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece was posted by [[site]] and is owned by of [[site]]. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at [[permalink]].

In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $140.52, for a total value of $562,080.00. Following the completion of the transaction, the chief executive officer now owns 319,807 shares in the company, valued at $44,939,279.64. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction on Monday, May 15th. The stock was sold at an average price of $109.48, for a total value of $32,844.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 26,105 shares of company stock valued at $3,394,859. 3.20% of the stock is owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of ATHN. Comerica Bank increased its position in athenahealth by 0.6% in the first quarter. Comerica Bank now owns 2,487 shares of the health services provider’s stock worth $302,000 after buying an additional 14 shares during the period. Fairfield Bush & CO. increased its position in athenahealth by 0.7% in the first quarter. Fairfield Bush & CO. now owns 4,923 shares of the health services provider’s stock worth $555,000 after buying an additional 35 shares during the period. Bell Bank increased its position in athenahealth by 2.6% in the first quarter. Bell Bank now owns 3,600 shares of the health services provider’s stock worth $406,000 after buying an additional 90 shares during the period. Baird Financial Group Inc. increased its position in athenahealth by 0.9% in the first quarter. Baird Financial Group Inc. now owns 11,818 shares of the health services provider’s stock worth $1,332,000 after buying an additional 105 shares during the period. Finally, US Bancorp DE increased its position in athenahealth by 0.6% in the first quarter. US Bancorp DE now owns 19,864 shares of the health services provider’s stock worth $2,238,000 after buying an additional 123 shares during the period.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.